RNA Replicons - A New Approach for Influenza Virus Immunoprophylaxis
Open Access
- 29 January 2010
- Vol. 2 (2), 413-434
- https://doi.org/10.3390/v2020413
Abstract
RNA replicons are derived from either positive- or negative-strand RNA viruses. They represent disabled virus vectors that are not only avirulent, but also unable to revert to virulence. Due to autonomous RNA replication, RNA replicons are able to drive high level, cytosolic expression of recombinant antigens stimulating both the humoral and the cellular branch of the immune system. This review provides an update on the available literature covering influenza virus vaccines based on RNA replicons. The pros and cons of these vaccine strategies will be discussed and future perspectives disclosed.Keywords
This publication has 95 references indexed in Scilit:
- RIG-I-like receptors: Sensing and responding to RNA virus infectionSeminars in Immunology, 2009
- The Influenza Virus EnigmaCell, 2009
- Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenzaInfluenza and Other Respiratory Viruses, 2008
- The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccinesVaccine, 2008
- The known unknowns of antigen processing and presentationNature Reviews Immunology, 2008
- Development and preclinical evaluation of an alphavirus replicon vaccine for influenzaVaccine, 2007
- Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoproteinVaccine, 2007
- Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protectionVirology, 2007
- Distinct Contributions of Vaccine-Induced Immunoglobulin G1 (IgG1) and IgG2a Antibodies to Protective Immunity against InfluenzaClinical and Vaccine Immunology, 2006
- Evaluating Replication-Defective Vesicular Stomatitis Virus as a Vaccine VehicleJournal of Virology, 2006